Skip to main content
logo
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.350
+0.020 (0.86%)
At close: Sep 25, 2026, 4:00 PM EDT
2.370
+0.020 (0.85%)
Pre-market: Sep 28, 2026, 7:05 AM EDT

Fate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2821131883699805,587
Market Cap Growth
141.70%-39.69%-49.04%-62.39%-82.45%-29.57%
Enterprise Value
203-23-101245865,018
Last Close Price
2.350.981.653.7410.0958.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
43.3817.0613.795.8010.18100.05
PB Ratio
1.790.550.591.002.038.23
P/TBV Ratio
1.840.550.591.002.038.23

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
31.35--1.956.0989.85

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.490.380.270.280.230.17
Net Debt / Equity Ratio
-0.51-0.61-0.61-0.57-0.67-0.74
Net Debt / EBITDA Ratio
0.650.941.101.231.112.37
Net Debt / FCF Ratio
0.741.121.571.531.152.35
Asset Turnover
0.020.020.030.110.120.07
Quick Ratio
4.755.697.398.134.177.70
Current Ratio
4.855.797.588.484.407.79
Return on Equity (ROE)
-60.75%-51.84%-54.21%-37.76%-48.46%-39.91%
Return on Assets (ROA)
-26.21%-24.12%-25.81%-19.65%-23.69%-17.57%
Return on Capital Employed (ROCE)
-58.20%-51.80%-48.60%-40.80%-52.10%-25.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-44.75%-120.27%-99.11%-43.64%-28.73%-3.80%
FCF Yield
-37.52%-98.85%-65.77%-37.53%-28.94%-3.82%
Buyback Yield / Dilution
-1.19%-4.49%-15.52%-1.64%-2.19%-15.00%
SEC Filings: 10-K · 10-Q